Loading...
QSAM Biosciences, Inc.
QSAM•PNK
Healthcare
Biotechnology
$8.30
$-16591.70(-99.95%)
QSAM Biosciences, Inc. (QSAM) Company Profile & Overview
Explore QSAM Biosciences, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
QSAM Biosciences, Inc. (QSAM) Company Profile & Overview
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas.
SectorHealthcare
IndustryBiotechnology
CEODouglas R. Baum
Contact Information
Company Facts
4 Employees
IPO DateAug 13, 2012
CountryUS